The GSK3 kinase has also been reported to be activated by hyperglycemia through the decrease in Caveolin-1 (Cav-1), which activates mTOR/SK6 pathway to activate GSK3, thereby increasing tau phosphorylation (45). The gene discussed is CAV1; the disease is Hyperglycemia.